Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
The Patient
|
February 28, 2024
Correction to: A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published Literature
Caroline Shaw, Louise Longworth, Bryan Bennett, et al.
Medical Care
|
February 24, 2005
Valuations of EQ-5D health states: are the United States and United Kingdom different?
Jeffrey A Johnson, Nan Luo, James W Shaw, et al.
Medical Care
|
October 15, 2005
Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index
Nan Luo, Jeffrey A Johnson, James W Shaw, et al.
Journal of Clinical Epidemiology
|
April 11, 2007
Racial/ethnic differences in preferences for the EQ-5D health states: results from the U.S. valuation study
James W Shaw, Jeffrey A Johnson, Shijie Chen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 25, 2023
Assessing the Content Validity of Preference-Based Measures in Cancer
Adam E J Gibson, Louise Longworth, Bryan Bennett, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 21, 2021
Equivalence testing of a newly developed interviewer-led telephone script for the EORTC QLQ-C30
Claire Piccinin, Madeline Pe, Dagmara Kuliś, et al.
The Journal of Sexual Medicine
|
February 2, 2010
Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile Function in patients treated with a phosphodiesterase type 5 inhibitor
James W Shaw, Gregory Reardon, David W Sandor, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 11, 2024
A Methodological Study to Compare Alternative Modes of Administration With Value EQ-5D Using Preference-Elicitation Techniques
Sarah R Hill, Adam Gibson, Yemi Oluboyede, et al.
Pharmacoeconomics
|
April 12, 2019
A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator's Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck
Kim Cocks, Marta Contente, Sarah Simpson, et al.
The American Journal of Managed Care
|
February 1, 2017
An expanded portfolio of survival metrics for assessing anticancer agents
Jennifer Karweit, Srividya Kotapati, Samuel Wagner, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
The Patient
|
February 28, 2024
Correction to: A Review of the Use of EQ-5D for Clinical Outcome Assessment in Health Technology Assessment, Regulatory Claims, and Published Literature
Caroline Shaw, Louise Longworth, Bryan Bennett, et al.
Medical Care
|
February 24, 2005
Valuations of EQ-5D health states: are the United States and United Kingdom different?
Jeffrey A Johnson, Nan Luo, James W Shaw, et al.
Medical Care
|
October 15, 2005
Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index
Nan Luo, Jeffrey A Johnson, James W Shaw, et al.
Journal of Clinical Epidemiology
|
April 11, 2007
Racial/ethnic differences in preferences for the EQ-5D health states: results from the U.S. valuation study
James W Shaw, Jeffrey A Johnson, Shijie Chen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 25, 2023
Assessing the Content Validity of Preference-Based Measures in Cancer
Adam E J Gibson, Louise Longworth, Bryan Bennett, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 21, 2021
Equivalence testing of a newly developed interviewer-led telephone script for the EORTC QLQ-C30
Claire Piccinin, Madeline Pe, Dagmara Kuliś, et al.
The Journal of Sexual Medicine
|
February 2, 2010
Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile Function in patients treated with a phosphodiesterase type 5 inhibitor
James W Shaw, Gregory Reardon, David W Sandor, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 11, 2024
A Methodological Study to Compare Alternative Modes of Administration With Value EQ-5D Using Preference-Elicitation Techniques
Sarah R Hill, Adam Gibson, Yemi Oluboyede, et al.
Pharmacoeconomics
|
April 12, 2019
A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator's Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck
Kim Cocks, Marta Contente, Sarah Simpson, et al.
The American Journal of Managed Care
|
February 1, 2017
An expanded portfolio of survival metrics for assessing anticancer agents
Jennifer Karweit, Srividya Kotapati, Samuel Wagner, et al.
Page
of 6